pharmaphorum Podcast

In this mini episode of the pharmaphorum podcast, web editor Nicole Raleigh spoke with Sylvana Sinha, founder, chair, and CEO of Praava Health, Bangladesh’s fastest growing healthcare brand.

In this episode of the pharmaphorum podcast, Editor in Chief Jonah Comstock chats with Howard Rose, head of health and wellness at Spatial about immersive audio: what it is, how it works, and how it can help in healthcare.

In the latest installment of the pharmaphorum podcast, Editor in Chief Jonah Comstock sits down with Russell Potterfield, CEO at Endevica Pharma. A biotech CEO who comes from the business and investment worlds, Russell now runs Endevica, which is working on a novel therapy for cachexia, a wasting syndrome that accompanies many cancers.

In this episode of the pharmaphorum podcast, host Jonah Comstock taps XIL Health’s Susan Lang to better understand why big tech’s ventures into healthcare seem to stumble more often than not.

In this special, live edition of the pharmaphorum podcast, recorded at the conclusion of Frontiers Health 2022, pharmaphorum Editor in Chief Jonah Comstock and pharmaphorum Web Editor Nicole Raleigh are joined by author, consultant, and podcast host Tony Estrella and Healthware Labs Managing Director Kristin Milburn to discuss their key takeaways from the show last week in Milan.

In mid-October, our Web Editor Nicole Raleigh and Deep Dive Editor Eloise McLellan traveled to Nice for the Reuters Pharma event. This special episode includes a conversation recorded on-site with Nicole, Eloise, Virtual Science AI CEO Thomas Hughes, and VSAI VP of global patient affairs Geraldine Reilly. And stay tuned for the second half of the episode, where Nicole speaks with Sabine Hutchison,...

In this episode of the pharmaphorum, Dr Paul Tunnah chats with Jeff Baxter, CEO of VBI Vaccines and Lee Taurman, executive vice president full service commercial at Syneos Health.  

Dr Marie-Louise Fjällskog, chief medical officer at Faron Pharmaceuticals, joins host Jonah Comstock for the pharmaphorum podcast this week to give us a primer on the tumour micro-environment, what it is, how we understand it, and what it means for the future of cancer care.

In the latest pharmaphorum podcast, Florian Baeres, Corporate Vice President for global medical affairs at Novo Nordisk, joins editor in chief Jonah Comstock to talk about the innovative once-weekly insulin currently in development and how it could change the game for people currently managing their type 2 diabetes with daily injections.

In today’s pharmaphorum podcast, editor in chief Jonah Comstock invites Drs Zachary and Geri Landman to tell their daughter Lucy’s story and the story of their new nonprofit Moonshots for Unicorns, which sets up a framework for parents in their circumstance to directly crowdfund research for rare single-gene disorders – starting with PGAP3.

Today on the pharmaphorum podcast, Editor in Chief Jonah Comstock welcomes Hedi Ben Brahim and Eric Quéméneur, CEO and chief science officer respectively of Transgene, to discuss cancer vaccines in general and Transgene’s recent work in the space in particular. 

In the newest episode of the pharmaphorum podcast, Editor in Chief Jonah Comstock welcomes Rebecca Guntern, vice president of medicines for Europe at Sandoz. Rebecca speaks about generics and biosimilars: what they are, why they’re important for medication access and healthcare cost sustainability, and what Sandoz has learned about succeeding in the off-patent world. She also touches on the patien...

On the latest instalment of the pharmaphorum podcast, editor in chief Jonah Comstock hosts Dr Benny Alouf, chief medical officer at Limbix to discuss his company’s digital therapeutic for teen depression.

On this week’s pharmaphorum podcast, editor in chief Jonah Comstock catches up with Dr. Marie Wikström Lindholm, SVP of molecular design at Silence Therapeutics. 

On the latest installment of the pharmaphorum podcast, editor in chief Jonah Comstock hosts Tony Mack, CEO at Virpax Pharmaceuticals, in the virtual studio. 

In this episode of the pharmaphorum podcast, editor in chief Jonah Comstock welcomes Dr. Jennifer Jones-McMeans, divisional vice president for global affairs for Abbott’s vascular business to discuss diversity and equity in clinical trials.

In the latest episode of the pharmaphorum podcast, editor in chief Jonah Comstock catches up with Pervaise Khan, Managing Director of Life Sciences, UK and Ireland, Accenture.

In the newest episode of the pharmaphorum podcast, editor in chief Jonah Comstock speaks with Mohammed Issa, Vice President of Commercial at US Janssen Neuroscience.

In the newest episode of the pharmaphorum podcast, Editor in Chief Jonah Comstock speaks with Dr Colin Banas, chief medical officer at DrFirst.   They discuss out of control drug pricing, especially in the United States, that has led to nonadherence and care rationing

In the latest episode of the pharmaphorum podcast, Editor in Chief Jonah Comstock speaks with Miruna Sasu, chief strategy officer of COTA and long-time pharma vet - before joining COTA last year, she headed up J&J’s Clinical Trial Feasibility and Advanced Analytics Team and led the Digital Health and Innovation Team at Bristol Myers Squibb.

In the latest episode of the pharmaphorum podcast, Editor in Chief Jonah Comstock speaks with Jennifer Goldsack, CEO of the Digital Medicine Society (DiMe). Tune in to hear about the year ahead in digital health and life sciences, as well as the need for partnership and collaboration more broadly between the pharma and tech worlds. Goldsack reports on what she heard in the virtual events surroundi...

In the latest episode of the pharmaphorum podcast, Dr Paul Tunnah speaks to head of Patient Engagement at Syneos Health, Marie Emms, and Elligo Health Research vice president, strategic partnerships, Keith Fern. Together they discuss the changing nature of clinical trials how COVID-19 impacted the sector, and the role technology is playing in supporting trial enrolment and retention.

This episode of the pharmaphorum podcast is the second in a limited series focused on patient engagement that’s being led clinician, consultant and patient advocate, Mark Duman.

In the first episode of the ELICIT podcast, a new series produced in partnership with Cerner Enviza, the guests discuss qualitative real-world evidence and a unique dementia project from Singapore.

Episode 45 of the pharmaphorum podcast heard from Dr Stuart Hill, how he’s seen the oncology landscape change and which of those he sees holding the most potential to improve patient outcomes.